切换至 "中华医学电子期刊资源库"

中华眼科医学杂志(电子版) ›› 2017, Vol. 07 ›› Issue (02) : 88 -91. doi: 10.3877/cma.j.issn.2095-2007.2017.02.007

所属专题: 经典病例 经典病例 文献

病例报告

自体穿透性角膜移植术治疗角膜内皮功能失代偿一例
徐玲娟1, 李贵刚1, 周雄武1,(), 李木1   
  1. 1. 430030 武汉市华中科技大学同济医学院附属同济医院眼科
  • 收稿日期:2017-04-13 出版日期:2017-04-28
  • 通信作者: 周雄武
  • 基金资助:
    国家自然科学基金(81200661,81470606); 湖北省自然科学基金(2014CFB973)

Autologous penetrating keratoplasty in the treatment of an eye with corneal endothelial decompensation: one case report

Lingjuan Xu1, Guigang Li1, Xiongwu Zhou1()   

  • Received:2017-04-13 Published:2017-04-28
  • Corresponding author: Xiongwu Zhou
引用本文:

徐玲娟, 李贵刚, 周雄武, 李木. 自体穿透性角膜移植术治疗角膜内皮功能失代偿一例[J]. 中华眼科医学杂志(电子版), 2017, 07(02): 88-91.

Lingjuan Xu, Guigang Li, Xiongwu Zhou. Autologous penetrating keratoplasty in the treatment of an eye with corneal endothelial decompensation: one case report[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2017, 07(02): 88-91.

图1 患者术前的双眼眼前段彩色照片 OD示右眼,OS示左眼。A图示患者右眼角膜水肿,经前房穿刺放液后可见前房积血;B图示患者左眼周边角膜白色混浊,中央角膜基质轻度混浊
图2 患者术前左眼的眼前节光学相干断层扫描图像 A图和B图示患者虹膜与角膜广泛粘连,前房深度为1.46 mm,角膜厚度为610 μm
图3 患者术前双眼的角膜内皮细胞检查结果图 A 图示右眼,B图示左眼。患者右眼角膜内皮细胞的密度在1721~2531个/mm2之间,细胞体积未见明显增大,密度较均匀;患者左眼中央区角膜内皮细胞的密度为846个/mm2,且角膜内皮细胞的体积增大,形态呈不规则状
图4 患者行左眼角膜移植术后1周、2个月及4个月的眼前段彩色照片与眼前节光学相干断层扫描图像 A图、B 图及C图分别为患者行左眼角膜移植术后1周、2个月及4个月的眼前节彩色照片;D图、E 图及F图分别为患者行左眼角膜移植术后1周、2个月及4个月的眼前节光学相干断层扫描图像。患者术后1周的角膜植片即恢复透明,植片对合好,无排斥反应。患者术后2个月及4个月的角膜植片厚度明显较术后1周时薄。因术中进行了虹膜粘连分离,术后1周时患者的角膜与虹膜无明显粘连,但在术后2个月及4个月时,角膜与虹膜仍发生粘连
[1]
Zhang W, Chen J, Fu Y, et al. The signaling pathway involved in the proliferation of corneal endothelial cells[J]. J Recept Signal Transduct Res, 2015, 35(6):585-591.
[2]
Güell JL, El HMA, Manero F, et al. Historical Review and Update of Surgical Treatment for Corneal Endothelial Diseases[J]. Ophthalmol Ther, 2014, 3(1-2):1-15.
[3]
Kinoshita S, Amano S, Inoue Y, et al. Grading for corneal endothelial damage[J]. Nippon Ganka Gakkai Zasshi, 2014, 118(2):81-83.
[4]
刘明娜,史伟云,金绘祥,等.324例大泡性角膜病变病因分析[J].临床眼科杂志,2007,15(3):209-211.
[5]
Morishige N, Sonoda KH. Bullous keratopathy as a progressive disease: evidence from clinical and laboratory imaging studies[J]. Cornea, 2013, 32(Suppl. 1):77-83.
[6]
Matthaei M, Sandhaeger H, Hermel M, et al. Changing Indications in Penetrating Keratoplasty: A Systematic Review of 34 Years of Global Reporting[J]. Transplantation, 2016, 106(4):363-371.
[7]
王艳,徐建江,孙兴怀.大泡性角膜病变病因分析[J].中国眼耳鼻喉科杂志,2005,5(6):363-364.
[8]
伍志琴,杨燕宁,邢怡桥.大泡性角膜病变的病因与临床治疗进展[J].眼科新进展,2007,27(8):625-629.
[9]
Yamaguchi T, Higa K, Suzuki T, et al. Elevated Cytokine Levels in the Aqueous Humor of Eyes With Bullous Keratopathy and Low Endothelial Cell Density[J]. Invest Ophthalmol Vis Sci, 2016, 57(14):5954-5962.
[10]
刘琳,马翔.角膜内皮影响因素分析[J].国际眼科杂志,2009,9(1):121-123.
[11]
Kumar RS, Baskaran M, Friedman DS, et al. Effect of prophylactic laser iridotomy on corneal endothelial cell density over 3 years in primary angle closure suspects[J]. Br J Ophthalmol, 2013, 97(3):258-261.
[12]
Koo EB, Hou J, Han Y, et al. Effect of glaucoma tube shunt parameters on cornea endothelial cells in patients with Ahmed valve implants[J]. Cornea, 2015, 34(1):37-41.
[13]
Lee JW, Chan JC, Chang RT, et al. Corneal changes after a single session of selective laser trabeculoplasty for open-angle glaucoma[J]. Eye (Lond), 2014, 28(1):47-52.
[14]
Hau S, Barton K. Corneal complications of glaucoma surgery[J]. Curr Opin Ophthalmol, 2009, 20(2):131-136.
[15]
Heindl LM, Koch KR, Bucher F, et al. Descemet membrane endothelial keratoplasty in eyes with glaucoma implants[J]. Optom Vis Sci, 2013, 90(9):e241-e244, e1029.
[16]
肖中男,胡竹林.大泡性角膜病变的临床治疗及研究进展[J].国际眼科杂志,2012,12(7):1277-1280.
[17]
杨付合,乔运峰,杨锦,等.大泡性角膜病变的手术治疗[J].中国中医眼科杂志,2009,19(6):343-345.
[18]
刘春香,赵海霞.大泡性角膜病变治疗进展[J].内蒙古医科大学学报,2009,31(2):164-167.
[19]
Siu GD, Young AL, Jhanji V. Alternatives to corneal transplantation for the management of bullous keratopathy[J]. Curr Opin Ophthalmol, 2014, 25(4):347-352.
[20]
Montero J, Sparholt J, Mely R. Retrospective case series of therapeutic applications of a lotrafilcon A silicone hydrogel soft contact lens[J]. Eye Contact Lens, 2003, 29(Suppl. 1):54-59, 192-194.
[21]
Paris FS, Goncalves ED, Morales MS, et al. Ultrasound biomicroscopy after palliative surgical procedures for bullous keratopathy: a descriptive comparative study[J]. Arq Bras Oftalmol, 2014, 77(6):382-387.
[22]
Alhayek A, Lu PR. Corneal collagen crosslinking in keratoconus and other eye disease[J]. Int J Ophthalmol, 2015, 8(2):407-418.
[23]
刘迎庆,杨方耀.穿透性角膜移植术治疗大泡性角膜病变[J].眼科新进展,2001,21(5):355-356.
[24]
Sheldon CA, McCarthy JM, White VA. Correlation of clinical and pathologic diagnoses of corneal disease in penetrating keratoplasties in Vancouver: a 10-year review[J]. Can J Ophthalmol, 2012, 47(1):5-10.
[25]
Dickman MM, Peeters JM, van den Biggelaar FJ, et al. Changing Practice Patterns and Long-term Outcomes of Endothelial Versus Penetrating Keratoplasty: A Prospective Dutch Registry Study[J]. Am J Ophthalmol, 2016, 170:133-142.
[26]
Rose L, Kelliher C, Jun AS. Endothelial keratoplasty: historical perspectives, current techniques, future directions[J]. Can J Ophthalmol, 2009, 44(4):401-405.
[27]
Price FW, Feng MT, Price MO. Evolution of Endothelial Keratoplasty: Where Are We Headed[J]. Cornea, 2015, 34(Suppl. 10):41-47.
[28]
张春琪.角膜内皮移植术治疗大泡性角膜病变的临床观察[D].吉林:吉林大学,2012.
[29]
Kim SE, Lim SA, Byun YS, et al. Comparison of Long-term Clinical Outcomes between Descemet′s Stripping Automated Endothelial Keratoplasty and Penetrating Keratoplasty in Patients with Bullous Keratopathy[J]. Korean J Ophthalmol, 2016, 30(6):443-450.
[30]
Okumura N, Kinoshita S, Koizumi N. Cell-based approach for treatment of corneal endothelial dysfunction[J]. Cornea, 2014, 33(Suppl. 11):37-41.
[31]
Thompson RW, Price MO, Bowers PJ, et al. Long-term graft survival after penetrating keratoplasty[J]. Ophthalmology, 2003, 110(7):1396-1402.
[32]
谢立信,王富华,史伟云.1997至2002年山东省眼科研究所穿透性角膜移植术的原因分析[J].中华眼科杂志,2006,42(8):704-708.
[33]
Kharod-Dholakia B, Randleman JB, Bromley JG, et al. Prevention and treatment of corneal graft rejection: current practice patterns of the Cornea Society (2011)[J]. Cornea, 2015, 34(6):609-614.
[34]
Lee JJ, Kim MK, Wee WR. Adverse effects of low-dose systemic cyclosporine therapy in high-risk penetrating keratoplasty[J]. Graefes Arch Clin Exp Ophthalmol, 2015, 253(7):1111-1119.
[35]
Hamrah P. High-risk penetrating keratoplasty[J]. Arch Soc Esp Oftalmol, 2005, 80(1):5-7.
[36]
Mclean IW, Pontigo M. Histopathological Findings In Bullous Keratopathy[J]. Invest Ophthalmol Vis Sci, 2002, 43(13):1093.
[37]
高平,刘慧霞,张康玉.自体穿透性角膜移植术2例[J].实用防盲技术,2011,6(1):33.
[38]
Hodkin MJ, Insler MS. Transplantation of corneal tissue from a blind eye to a high-risk fellow eye by bilateral penetrating keratoplasty[J]. Am J Ophthalmol, 1994, 117(6):808-809.
[39]
Tannen B, Zarbin MA, Bhagat N, et al. Corneal autograft and allograft in a 10-month-old premature boy with acquired bilateral corneal opacities[J]. Cornea, 2011, 30(8):905-906.
[40]
Yoeruek E, Szurman P. Autologous Descemet membrane endothelial keratoplasty[J]. Cornea, 2012, 31(2):208-210.
No related articles found!
阅读次数
全文


摘要